Results from a new study reveal that targeting interferon kappa, a protein made by skin cells, may reduce the severity of psoriasis. Researchers say the findings will bring physicians one step closer to optimizing treatments for patients with the autoimmune disease.
Click here for original story, For psoriasis, targeting skin protein may help control inflammation
Source: ScienceDaily